06660.HK
AIM Vaccine Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.48
−6.65%Margins
Gross margin
65.0%
EBITDA margin
-3.3%
EBIT margin
-19.0%
Net margin
-66.8%
FCF margin
-9.6%
-25.2%
Return on equity
-10.5%
Return on assets
-4.3%
Return on invested capital
0.15x
Asset turnover
HKD 136.7M
Cash from operations
HKD 0.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026